+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 29Weeks - 33Weeks
All Genders
ID07816601

Early Iron Supplementation Compared to Standard Feeding Protocol in Very Preterm Infants Receiving Donor Breast Milk

Led by AdventHealth · Updated on 2026-09-11

17

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research investigates very preterm infants born between 29.0 and 32.6 weeks of gestational age receiving donor breast milk DBM. The study evaluates whether starting iron supplementation earlier, when infants reach 80 mlkgday of enteral feeds, increases serum ferritin and hematocrit levels at 14 and 28 days of life compared to the current practice of starting at full feeds 140 to 160 mlkgday. The rationale is based on evidence that DBM has lower iron content due to pasteurization and that iron levels may impact neurodevelopment in preterm infants. Participants will receive oral ferrous sulfate supplementation at 2-4 mgkgday starting approximately 4-6 days after birth when they reach the feeding volume target. Blood samples will be taken at day 14 4 days and day 28 4 days or prior to discharge, whichever is earlier, to measure serum ferritin and hematocrit levels. These blood draws coincide with routine clinical blood collections to minimize discomfort. Iron supplementation is given earlier than the usual protocol that initiates supplementation around day 14. During the study, infants will be monitored in the neonatal intensive care unit with regular assessments of blood iron markers. Researchers will track serum ferritin and hematocrit levels at the specified time points to determine the effect of earlier iron supplementation. The total participation period spans from early feeding stages until day 28 or hospital discharge, with safety and growth monitored as part of routine care. The trial is sponsored by AdventHealth and aims to optimize iron supplementation timing to potentially improve neurodevelopmental outcomes.

CONDITIONS

Brief Title

Donor Breast Milk 2

Research Team

A

Anoop Pulickal, MD, PhD

D

Deborah Ruth, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here